Concepedia

Thomas Görlitz

TG

Statistics

Publications

6

Citations

113

H-Index

6

Active since

2020

Affiliations

Bezirkskrankenhaus Augsburg(Current)

Ludwig-Maximilians-Universität München

Technical University of Munich

University of Augsburg

GGNet

Thomas Görlitz is an author at Bezirkskrankenhaus Augsburg specializing in psychopharmacology, medicine, and schizophrenia pharmacotherapy.

Publications per year

2020–2023

6

Publications

6

Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders

Cynthia Okhuijsen‐Pfeifer, Marte Z. van der Horst, Chad Bousman et al. · Translational Psychiatry · 2022 · 32 citations · Full text

Medicine, Genetics, Psychiatry +17

Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trial

Alkomiet Hasan, Astrid Roeh, Stefan Leucht et al. · Contemporary Clinical Trials Communications · 2020 · 22 citations · Full text

Medicine, Pharmacology, Psychiatry +16

Associations Between Polygenic Risk Score Loading, Psychosis Liability, and Clozapine Use Among Individuals With Schizophrenia

Bochao Lin, Justo Pinzón-Espinosa, Elodie Blouzard et al. · JAMA Psychiatry · 2022 · 19 citations · Full text

Medicine, Pharmacotherapy, Psychiatry +17

Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions

Marte Z. van der Horst, Yoeki Meijer, Nini de Boer et al. · Psychiatry Research · 2023 · 18 citations · Full text

Medicine, Pharmacology, Psychiatry +17

Effects of Early Clozapine Treatment on Remission Rates in Acute Schizophrenia (The EARLY Trial): Protocol of a Randomized-Controlled Multicentric Trial

Elias Wagner, Wolfgang Strube, Thomas Görlitz et al. · Pharmacopsychiatry · 2023 · 12 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +16

1–5 of 6